Young Investigator Research Grant

Goals:

  • To foster research within the SPP by providing funds to young investigators in the field of pediatric pathology.
  • To fund a pilot project which will lead to long-term research support from other granting agencies.

Use of Funds:

The funds are to be used to facilitate basic or applied research by a young investigator in the field of pediatric pathology. Research into any aspect of pediatric disease will be considered, including morphological, biochemical, behavioral, physiological, genetic, and epidemiological studies. Appropriate expenditures include capital equipment, reagents and supplies, research-related travel, salary supplementation, service costs (e.g., electron microscopy, histology), and animal care costs. Indirect costs are not allowed.

Eligibility:

Applicants must meet ALL of the following criteria:

  • Hold the degree of MD, PhD, DDS, DVM, or DO;
  • Be a resident or fellow, full-time, in an accredited pathology training program, OR be a post-doctoral fellow working in the laboratory of a faculty/staff person in pediatric pathology, OR be a faculty/staff person in pediatric pathology practicing in his or her first academic appointment at the level of instructor or assistant professor for 7 years or less;
  • Be a member of the SPP OR be sponsored by a member of the SPP.

Amount of Award:

A single annual award of $25,000 will be made.

Selection Process:

Complete applications must be received by the Research Committee Chair no later than Friday, January 28, 2022. The SPP Research Committee will review all applications and announce the award at the Spring SPP Meeting in Los Angeles, California. Consideration will be given to scientific merit and the background and career goals of the applicant. The award will be funded July 1, 2022.

Application Instructions:

All portions of the application must be completed. Incomplete applications will not be considered. Although Institutional Review Board (for human studies) or Animal Care Committee (for animal studies) approval will be required before the award is funded, such approval can be deferred until after an initial funding decision has been made.

A complete application includes ALL of the following:

  • Cover Sheet (Please click to download: MS Word | PDF )
  • Research Proposal (limited to 5 pages, excluding references), to include:
    • Specific aims
    • Background and significance
    • Preliminary data, if available (not required)
    • Research design and methods
  • Itemized budget (limited to 1 page)
  • Applicant's biosketch (NIH format)
  • Personal Statement (limited to 1 page) - The applicant should indicate how the proposed research project fits with his/her personal career goals
  • Sponsor's letter of support (if applicant is not an SPP member)
  • Letter of support from Chairperson or appropriate institutional representative which should indicate that adequate resources are available at the applicant's institution to support the proposed project and the salary support that will be provided for the applicant.

Please submit all components of the application electronically as a single PDF file to [email protected]. No hard copy submission is necessary.

Submission Deadline: Friday, January 28, 2022 at 11:59pm PT.

Young Investigator Grant Winners

Year # Name Institution Proposal
1997 NA (Not awarded)    
1998 NA

Russell Broaddus,
MD, PhD

Baylor Specific cytokine-directed immunotherapy in a mouse model of inflammatory bowel disease
1999 10 Hector Melin-Aldana NA Molecular control of the regenerative response of the developing liver
2000 NA Monique DePaepe NA Fas/Fas ligand in the pathogenesis of bronchopulmonary dysplasia
2001 4 Michael Fritsch University of Wisconsin The role of histone acetylation in regulating embryonic stem cell differentiation
2002 NA (Not awarded)    
2003 7 Roberto Gianini NA Transgenic expression of surviving in NOD mouse islets
2004 NA Rene L. Galindo, MD, PhD UT Southwestern Molecular Pathogenesis of Alveolar Rhabdomyosarcoma
2005 NA

Maureen
O’Sullivan, MD

BC Children's Hospital Role of MLL4 in Sarcomagenesis
2006 NA

Jason
Jarzembowski,
MD, PhD

University of Michigan Genomic and proteomic heterogeneity of neuroballistic tumor component cell types
2007 7 Scott Boyd Stanford Prognostic significance and biological roles of microRNAs in pediatric acute lymphoblastic leukemia
2008 6 Christopher Pearson

Nationwide Children's Hospital

The Identification of Myotubularin Interacting Proteins Provides Insight Into the Pathogenesis of X-linked Myotubular Myopathy
2009 8

Kathryn
Wikenheiser-Brokamp, PhD

Cincinnati Children's Hospital Role of DICER1 in the Pathogenesis of Pleuropulmonary Blastoma
2010 7

Kyle Kurek, MD,
PhD

Children's Hospital of Boston Metachondromatosis
2011 NA

Dinesh Rakheja,
MD, PhD

Children's Hospital of Dallas PTPE and Wilms tumorigenesis
2012 NA

Angshumoy Roy,
MD, PhD

Baylor Defining the role of MDM4 gene amplification and overexpression in hepatoblastoma
2013 6

Gabrielle Rizzuto,
MD, PhD

UCSF Immune response to infection at the maternal-fetal interface
2014 6

Nikolina Dioufa,
MD, MSc

Harvard An anchorage independent growth system as a model to study the molecular pathways that lead to drug resistance and metastasis in Ewing Sarcoma
2015 9 Jeff Terry, MD, PhD BC Children's Identification of bacteria by in situ molecular visualization in pediatric Crohn's disease
2016 6

Elena Repnikova, PhD

Children's Mercy Hospital, Kansas City Characterization of copy number variations in genomic regions containing long non-coding RNA using DNA microarray
2017 10

Shengmei Zhou, MD

Children's Hospital of Los Angeles

Integrated Genomic Analysis of High Risk
Hepatoblastoma

2018 9 Gabrielle Rizzuto, MD, PhD UCSF Profiling the maternal T cell response to placental antigen
2019   Jessica Saunders, MD

Seattle Children's Hospital

Luminex-based diagnosis of Hirschsprung disease
2020   Jennifer Pogoriler, MD, PhD Children's Hospital of Philadelphia

Molecular Evaluation of Mucinous Cell Clusters in
Congenital Pulmonary Airway Malformations to
Determine Clonality and Relationship to Adult Mucinous
Tumors

2021   Jonathan Bush, MD, FRCPC BC Children's & Women's Hospital and Health Centre, Vancouver, Canada High-Resolution Mass Spectrometry Proteomic Analysis in Osteosarcoma